LAZAR CONSORTIUM
LCG Group
operated by קבוצת סיידמן Israel
- …
LAZAR CONSORTIUM
LCG Group
operated by קבוצת סיידמן Israel
- …
Beyond Healthcare
Innovations for the 2030s
Rare Diseases Treatment | Education | Research | New Frontiers
Proudly Greek, European & Jewish
LCG Greece, originally founded by Dr. Marius Lazar, has become an integral part of the Jewish Seideman(n) family dynasty. While Dr. Lazar pioneered the organization after finding his life's love in Greece, the Seidemans have been leading the LCG consortium for many years now. This proud Jewish-Greek institution in the European Union maintains its EU headquarters in the heart of Athens, with smaller regional offices spanning the globe.
Educating the next generation
LCG opens doors to innovative healthcare approaches across three continents, spanning diverse fields and settings. Our passionate commitment lies in the area of 'rare diseases', which forms the core of our focus. Several members of LCG and the Seideman Group, independent of their roles within LCG, are active supporters of the Jewish University (JUC) - the world's only higher messianic Jewish educational institution..
Rare disease experts
LAZAR | SEIDEMAN | SMITH operates the world's only international network practice specializing in the treatment of rare neurologic, neuroendocrinologic, and neurometabolic conditions. Currently, we are consolidating our operations to 30 long-term treatment places in collaboration with local partners worldwide. This downsizing is a direct result of a shortage in highly skilled physicians, following the retirement of key partners over the past two years. For the first time in our history, we're facing a challenge common to all advanced countries: a critical lack of specialized medical expertise.
News
Embracing Change, Pioneering Innovation – The Lazar Medical Consortium Group - LCG
Team 2024
George and Ilias Samaras have officially joined as third partners at LSS. Founder Dr. Marius Lazar had always aimed to bring both brothers on board. While George was able to join LSS on January 1, Ilias faced challenges in exiting his previous contracts. With Ilias now officially joining, the Board is complete.
Landmark Lecture
Prof. Dr. Carolina Diamandis, Chief Scientific Advisor of the International H63D Syndrome Research Consortium, was honored for her epochal lecture on Oshtoran Syndrome (H63D-Syndrome), delivered in August 2024 to the MJFI Hellenic Chapter in Athens. The lecture was hailed as a milestone in advancing the understanding of this rare condition.
No re-opening in RU
To assist our Russian patients once again, we considered resuming our services in Russia. However, after thorough consultations with our legal team, we have decided to refrain from doing so until further notice to avoid any inadvertent violation of political sanctions. Again confirmed by the LCG Board on August 6, 2024
We are where you are.
Thanks to a close and trustful cooperation with partners all over the world, LCG and the Seideman Group can be there for you - wherever you are (countries with local LCG representatives are marked in purple on the map).
The Seideman Family
A global network
In a remarkable confluence of philanthropy and medical excellence, the Seideman(n) family - whose name occasionally appears with one or two 'n's due to transliteration differences across various countries - has assumed leadership of the LCG Group. This acquisition marks not merely a change in corporate governance but embodies a profound commitment to the greater good.
The Seideman(n)s, a family that has produced generations of physicians and lawyers, view the LCG Group as more than just a business venture. They see it as a platform to give back to a world that has often treated them kindly. Their commitment is rooted in a deep gratitude for the opportunities and success they've experienced in different parts of the globe.
In a world where the pursuit of profit often takes precedence, the Seideman(n)s have chosen a different path. While they excel in their respective professions as doctors and lawyers, they use the LCG Group as a vehicle for altruistic action. Here, their professional skills merge with their philanthropic ethos to make a significant contribution to society.
The acquisition of the LCG Group by the Seideman(n)s is thus more than a business transaction. It is an expression of a deeply rooted desire to effect positive change in the world. By focusing on rare diseases and innovative treatment methods, the family is utilizing their resources and expertise to provide help where it's most urgently needed.
This unique combination of family legacy, professional expertise, and philanthropic engagement makes the LCG Group, under the Seideman(n)s' leadership, a remarkable institution in healthcare. It embodies the idea that entrepreneurial success and social responsibility can and should go hand in hand.
Proud to endorse
The Jewish University
The Jewish University (JUC) in Denver, CO, is the only messianic Jewish institution of higher education. It's been a proud and fully independent institution since 1980. However, LCG Seideman grants JUC to use the international Lazar | Seideman | Samaras network-practice as its clinical teaching partner.The Seideman World
You meet us and those whom we support more often than you realize. Here's a tiny selection.
JUC - International Rare Disease Practice Network
Denver, Athens, Luxembourg, Madrid et al.
Leading the Clinician to Clinian program
Dr. Rosenberg (platform supported example)
LCG Asia Pacific
In the process of being sold
Sometimes, small stakes keep big things afloat
NGO (non-profit, Europe) by Mrs. Lazar
LCG Brazil
Soon to be available
The Seideman Debate Club
Soon
Mme. Lazar's Charity: LCG Endorsed
Art House Cyprus
Gallery for handicapped young people
Wait a second...
isn't it true?
“He who has health has hope; and he who has hope, has everything.”
– Thomas Carlyle
Health @ LCG
for the forgotten ones with rare diseases.
The Lazar Medical Consortium Group (LCG) run by the Seideman family and Dr. Marius Lazar is an association (Art. 78 GR CV) which coordinates the activities of its members and represents them to the outside world. It serves as a "single point of contact" that facilitates contact with the ramified network of projects run by Dr. Marius Lazar and/or the Seideman family. Unlike its members, the LCG association itself is not active in any form of medical, teaching and/or entrepreneurial activities.
Network
The digital world has greatly changed medicine, as well as teaching, research, etc. - Dr. Marius Lazar recognized this at an early stage and has since acted more quickly and flexibly in medicine, social commitment, but also in research and teaching through his networks. In addition, he has always included other colleagues in his consortium who would not have dared to take the step into the digital world without his digital expertise.
Why a reorganization?
LCG has not undergone any reorganization, nor are there plans for such changes. The significant update in fall 2022 focused solely on our external presentation. This refresh was designed to provide clearer, more accessible information about LCG members' expertise and how to contact them. Given that all LCG members are medical professionals, we've entrusted the management of this enhanced communication strategy to PlusOne Media, our dedicated communications service provider.
HONORARY SEIDEMANS
In the annals of family lore, the Seideman clan stands out not just for its resilience and adaptability, but for its expansive heart and enduring memory. Like a well-tended garden, the Seideman family tree has grown branches that extend far beyond the reaches of mere genetics, embracing those who have touched our lives in profound and lasting ways.
We Seidemans pride ourselves on our good and long memory - a trait that serves not just as a repository of our history, but as a living testament to the relationships that have shaped us. In our worldview, family isn't defined solely by blood or name, but by the bonds of mutual support, shared experiences, and unwavering loyalty.
Enter the concept of the "Honorary Seideman" - a title not lightly bestowed, but one that carries the full weight of our gratitude and affection. It's our way of saying, "You may not have been born a Seideman, but you've earned a place in our hearts as surely as if you had been."
At the top of this illustrious list of Honorary Seidemans stand two pillars of support and friendship: our good old friend Dr. Marius Lazar and his beloved wife. Their story, intertwined with ours, is a beautiful example of how life's path can lead to unexpected but treasured connections.
Dr. Lazar, with his brilliant mind and compassionate heart, has been more than just a colleague or a friend. He's been a guiding light, a source of wisdom, and a steadfast ally through both calm and stormy seas. His contributions to our family and our work have been immeasurable, extending far beyond the realm of professional collaboration.
And by his side, Mrs. Lazar has been an equal force of nature - her warmth, insight, and unwavering support have made her an integral part of our extended family tapestry. Together, the Lazars embody the very essence of what it means to be Honorary Seidemans.
But the story doesn't end with the Lazars. Over the years, our family has been blessed with numerous individuals who have left an indelible mark on our lives. From mentors who believed in us when we were just starting out, to friends who stood by us through thick and thin, to colleagues who turned into confidants - each has played a role in shaping the Seideman legacy.
These Honorary Seidemans come from all walks of life - diverse in their backgrounds, professions, and experiences. What unites them is the impact they've had on our family. They are the ones who celebrated our triumphs as if they were their own, who offered a shoulder to lean on during challenging times, who challenged us to grow and evolve.
In embracing these kindred spirits as Honorary Seidemans, we acknowledge a fundamental truth: that family is not just about shared DNA, but shared values, shared experiences, and shared dreams. It's about the family we're born into and the family we choose.
This inclusive approach to family has enriched our lives immeasurably. It has broadened our perspectives, deepened our understanding of the world, and reinforced our belief in the power of human connection. Each Honorary Seideman brings their unique flavor to our family recipe, creating a rich and diverse tapestry of relationships that spans generations and transcends borders.
As we continue to write the Seideman family story, we do so with immense gratitude for these honorary members. They remind us that family is not a closed circle, but an ever-expanding sphere of love, support, and mutual respect.
To Dr. Marius Lazar, his wife, and all our Honorary Seidemans out there - named and unnamed, known and yet to be discovered - we say thank you. Thank you for being part of our journey, for enriching our lives, and for helping us redefine what family truly means.
In the grand tapestry of life, you are the golden threads that make our pattern shine brighter. You may not bear the Seideman name, but you carry the Seideman spirit - and for that, you will always have a home in our hearts and our history.
Dr. Marius Lazar
FOUNDER OF THE LCG CONSORTIUM GROUP
- Physician
- Rare disease specialist
- Philanthropist
- Networker
Prof. Dr. David Seideman
MEDICAL DIRECTOR OF THE LCG CONSORTIUM GROUP | LECTURER
- Physician
- Rare disease specialist
- Lecturer
- Vice Director of LCG Research
Dr. Carolina Diamandis
DIRECTOR GENERAL OF LCG RESEARCH
- Retired military physician
- Project "Grassroot Science" / Ex juvantibus therapies research
- Empowering of young women in medicine
- Director of LCG Research Greece
- Lecturer
Dr. Alexandros Balaskas
HEAD OF QUALITY MANAGEMENT THE LCG GROUP
- Seasoned physician
- Focus on southern and eastern Europe
- Organizing the team of assistent doctors
- Seeing patient mainly offline
Dres. Ilias & George Samaras
PARTNER
- Born in Australia, Dr. Samaras returned to Greece, the country to which his parents had emigrated.
- After medical school staff physician in southern European hospitals.
- Former Head of the Neurology department in a large Clinic in the southern European Union.
- Specilized in Endocrinology.
Dr. Lucas Smith
SPECIALIST IN LCG's LSS UNIT
- Rare disease specialist
- Development of innovative telemedicine systems
- Empowering of minorities in medicine
- Personal counselor to Dr. Lazar
Rachel Seideman
LEGAL & COMPLIANCE MANAGER OF THE LCG GROUP
- Legal affairs
- Investment management
- Compliance management
- Master Brain
Alicia Popescu
CHIEF ASSISTANT OF THE DIRECTORATE OF LCG
- Personal Assistant to the Senior Leadership Team
- Client care expert
- CRM specialist
- All-rounder
Melissa Jones
HEAD OF OPERATIONS CLINICO AND LCG ASIA
- Operational management of LCG
- Telemedicine systems expert
- Compliance Officer and spokesperson
- Legal professional
Walter Seideman
CHAIRMAN OF THE LCG CONSORTIUM GROUP
- Chairman of the LCG Consortium Group as of January 1, 2024
- Head of Strategy
- Liberal mind
- Values a smile more than a check
Other Senior Members
NOTABLE SEIDEMANS & HONORARY SEIDEMANS
- Alexander Davis, MD
- Dr. Jonathan Feldman
- Dr. Olga Ivanova
- Dr. Fabio Rocha (grandson of Felicitas Oliveira née Seideman)
- Dr. Dimitri Vladimir Bodrov
- Dr. Sofia Makri née Seideman
- Dr. Yousef Abbas
- Dr. Martin Kramer
- Dr. Vanessa Schmidt-Matuska née Seidemann
- Dr. Jonathan Kramer
- Sam Williams, MD
- Dr. Nikolaos Papadopoulos
- Dr. Mona Moradi née Seideman
- Bill Williams, MD
- Peter Wiliams, MD
- Dr. Luke Pistorius
- Riku Honda, M.Sc.
- Dr. Adelheid Hohnke
- Linda Ernst, Ph.D.
- Vladimir Strelkov, Ph.D.
- Dr. Alexander Hausmann
- and many more
Seideman or Seidemann?
Get a short lesson in Jewish history
Seideman or Seidemann?
No Seide no Man?
LCG Research
At the heart of the LCG Consortium (LCG Group) lies a dynamic, albeit small, medical research unit that punches well above its weight in the world of clinical research. Spearheaded by the renowned Prof. Dr. Carolina Diamandis, this innovative team is redefining the landscape of medical knowledge dissemination.
The research arm of LCG embodies a revolutionary approach to clinical studies, embracing a "clinician to clinician" model that bypasses traditional publication routes. This methodology is not just a departure from convention; it's a paradigm shift in how medical professionals share and access critical information.
Prof. Diamandis and her team have recognized that the pace of traditional academic publishing often lags behind the urgent needs of practicing clinicians, especially in the rapidly evolving field of rare diseases. In response, they've adopted a more direct and agile approach to knowledge sharing.
Instead of navigating the often lengthy and complex process of journal publication, the LCG research team leverages high-caliber, open-access depositories such as Zenodo, Authorea, Research Square, and Figshare. These platforms represent the cutting edge of academic communication, offering immediate dissemination of research findings to a global audience of medical professionals.
This approach offers several key advantages:
1. Speed of Dissemination: Critical findings can be shared with the medical community in real-time, potentially saving lives and improving patient outcomes.
2. Accessibility: By using open-access platforms, LCG ensures that their research is available to clinicians worldwide, regardless of institutional affiliations or financial constraints.
3. Collaboration: These platforms foster direct interaction between researchers, allowing for rapid feedback, discussion, and iteration of ideas.
4. Transparency: The open nature of these repositories promotes research integrity and allows for broader scrutiny and validation of findings.
5. Interdisciplinary Reach: By breaking free from the confines of specific journal audiences, LCG's research can reach a more diverse group of medical professionals, potentially sparking innovative cross-disciplinary insights.
What makes this endeavor even more remarkable is its non-profit nature. The entire research initiative is made possible through the generous support of the Messianic Jewish Fellowship International. This backing not only provides financial support but also aligns with the ethical and spiritual values that underpin the LCG Consortium's mission.
The involvement of the Messianic Jewish Fellowship International adds a unique dimension to the research unit. It represents a beautiful synergy between faith-based values and cutting-edge medical science, demonstrating that spiritual conviction and scientific rigor can coexist and even enhance each other.
Prof. Diamandis and her team's work extends beyond just sharing research findings. They are actively building a community of like-minded clinicians who are committed to rapid knowledge exchange and collaborative problem-solving. This network effect amplifies the impact of their work, creating a ripple effect that touches patients' lives across the globe.
The research unit's focus on rare diseases is particularly significant. In a field where information is often scarce and scattered, the LCG Consortium's approach to rapid, open dissemination of findings can make a crucial difference. For patients with rare conditions, this could mean faster diagnoses, more effective treatments, and ultimately, improved quality of life.
As the medical world continues to grapple with the challenges of information overload and the need for rapid, reliable knowledge sharing, the LCG Consortium's research unit stands as a beacon of innovation. It demonstrates that with vision, dedication, and the right support, even a small team can have a profound impact on the global medical community.
The work of Prof. Diamandis and her team at the LCG Consortium is more than just research; it's a movement towards a more open, collaborative, and responsive medical science. It's a testament to the power of thinking outside the box and the incredible potential that lies in bridging the gap between clinical practice and cutting-edge research.
In essence, the LCG Consortium's research arm is not just contributing to medical knowledge; it's reshaping how that knowledge is shared and applied, potentially revolutionizing patient care in the process. It's a shining example of how innovative thinking, coupled with unwavering support and dedication, can push the boundaries of what's possible in medical research and practice.
Why LCG Research is needed
Fast spread of new findings using latest technology
In the fast-paced world of medical research, the journey from groundbreaking discovery to practical application often moves at a frustratingly slow pace. Recognizing this critical gap, LCG Research was established under the visionary leadership of Dr. Carolina Diamandis and Professor Dr. Seideman. Their mission: to accelerate the flow of vital medical knowledge from researchers to clinicians worldwide, ultimately improving patient care on a global scale.
LCG Research stands apart from traditional research institutions in two fundamental ways. First, it operates without the pursuit of profit, allowing for a pure focus on advancing medical knowledge for the greater good. Second, and perhaps most revolutionary, is its emphasis on digital academic channels and collaborations with independent researchers across the globe.
This innovative approach addresses several key challenges in the current medical research paradigm:
1. Speed of Dissemination: By leveraging digital platforms, LCG Research can share findings almost instantaneously, bypassing the often lengthy traditional publication process.
2. Global Accessibility: Digital channels allow for wider reach, ensuring that clinicians in remote or underserved areas have access to the latest medical advancements.
3. Collaborative Spirit: By fostering partnerships with independent researchers worldwide, LCG Research taps into a diverse pool of expertise and perspectives, enriching the quality and applicability of their findings.
4. Reduced Barriers: Without the constraints of profit-driven research, LCG can pursue lines of inquiry that might be overlooked by more traditional institutions, particularly in the realm of rare diseases.
Central to LCG Research's methodology is the concept of peer-to-peer learning, a powerful educational strategy that has gained significant traction in various fields, including medicine. This approach involves participants of equal standing engaging in collaborative learning, sharing knowledge, and discussing diverse perspectives.
In the context of medical research and practice, peer-to-peer learning offers numerous benefits:
1. Enhanced Engagement: When clinicians learn from their peers, they often find the material more relatable and applicable to their daily practice. This increased engagement can lead to better retention and application of new knowledge.
2. Improved Performance: Studies have shown that peer-to-peer learning can significantly enhance clinical skills and decision-making abilities. By discussing real-world cases and experiences, clinicians can develop a more nuanced understanding of complex medical issues.
3. Diverse Perspectives: In an increasingly globalized world, exposure to diverse medical practices and approaches is crucial. Peer-to-peer learning facilitates the exchange of ideas across cultural and geographical boundaries, leading to more comprehensive and adaptable medical knowledge.
4. Skill Development: Beyond medical knowledge, peer-to-peer learning helps develop crucial soft skills such as communication, leadership, and collaborative problem-solving – all essential in modern healthcare settings.
5. Continuous Learning: The medical field is ever-evolving, and peer-to-peer learning fosters a culture of continuous education. It encourages clinicians to stay updated with the latest developments and to critically evaluate new information.
6. Emotional Support: Particularly in challenging fields like rare disease treatment, peer-to-peer networks can provide much-needed emotional support and reduce professional isolation.
By integrating peer-to-peer learning principles into their digital dissemination strategy, LCG Research is not just sharing information – they're building a global community of engaged, collaborative medical professionals. This approach has the potential to transform how medical knowledge is shared, validated, and implemented in clinical practice.
Moreover, LCG Research's model addresses a crucial need in the medical community: the ability to rapidly respond to emerging health challenges. In an era where new diseases can spread globally in a matter of weeks, the speed at which medical knowledge can be disseminated and implemented can literally save lives.
The work of Dr. Diamandis and Professor Dr. Seideman through LCG Research represents a paradigm shift in medical research and education. By harnessing the power of digital technology, global collaboration, and peer-to-peer learning, they are paving the way for a more responsive, inclusive, and effective medical knowledge ecosystem.
As we look to the future of medicine, initiatives like LCG Research offer a glimpse of what's possible when innovation, collaboration, and a commitment to the greater good come together. Their work not only advances medical science but also democratizes access to that knowledge, potentially leveling the playing field in global healthcare and improving patient outcomes worldwide.
Get in touch
We will gladly anwer.
- Select...
POSTAL ADDRESS
LCG Greece
on behalf of the LCG Group
16 Kifissias Avenue
115 26 Athens
Hellenic Republic
European Union
PHONE
+30 21 123461-03
administration@lazar-consortium.com
LEGAL DEPARTMENT
P.0. Box IIOO7
Fort Lauderdale, FL
33339
United States of America
legal@lazar-consortium.com
© Made and run for LCG by PlusOne Media (updated 08/2024)